US4431657A
(en)
*
|
1982-05-24 |
1984-02-14 |
Ayerst, Mckenna & Harrison Inc. |
Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
|
KR20010086657A
(ko)
*
|
2000-03-02 |
2001-09-15 |
성재갑 |
아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
|
SI1318997T1
(sl)
*
|
2000-09-15 |
2006-12-31 |
Vertex Pharma |
Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
PT1317448E
(pt)
*
|
2000-09-15 |
2005-08-31 |
Vertex Pharma |
Compostos de pirazole uteis como inibidores de proteina-quinase
|
CN1926132B
(zh)
*
|
2000-09-15 |
2010-12-29 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的吡唑化合物
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
CN100408573C
(zh)
|
2000-12-21 |
2008-08-06 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的吡唑化合物
|
KR100406634B1
(ko)
*
|
2001-03-12 |
2003-11-20 |
주식회사 엘지생명과학 |
3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
|
CA2460145C
(en)
|
2001-09-26 |
2011-04-26 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
EP2322521B1
(en)
*
|
2002-02-06 |
2013-09-04 |
Vertex Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of GSK-3
|
FR2836915B1
(fr)
*
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
WO2003078427A1
(en)
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azolylaminoazines as inhibitors of protein kinases
|
ES2411655T3
(es)
|
2002-05-17 |
2013-07-08 |
Pfizer Italia S.R.L. |
Derivados de aminoindazol activos como inhibidores de quinasas, procedimiento para su preparación y composiciones farmacéuticas que los comprenden
|
MY141867A
(en)
*
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
ATE339419T1
(de)
|
2002-08-02 |
2006-10-15 |
Vertex Pharma |
Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
|
WO2004041285A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Amgen Inc. |
Antiinflammation agents
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
WO2005056547A2
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
AU2006279376B2
(en)
|
2005-08-18 |
2011-04-14 |
Vertex Pharmaceuticals Incoporated |
Pyrazine kinase inhibitors
|
EP1954277B1
(en)
|
2005-11-03 |
2017-01-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
JP2009533474A
(ja)
*
|
2006-04-14 |
2009-09-17 |
アボット・ラボラトリーズ |
バニロイドサブタイプ1(vr1)受容体を阻害するインダゾリルウレアの製造方法
|
NZ576750A
(en)
|
2006-11-02 |
2012-01-12 |
Vertex Pharma |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
CA2673353A1
(en)
|
2006-12-19 |
2008-06-26 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
CN101663295B
(zh)
|
2007-03-09 |
2014-11-05 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的氨基嘧啶类化合物
|
ES2374335T3
(es)
|
2007-03-09 |
2012-02-15 |
Vertex Pharmaceuticals Incorporated |
Aminopirimidinas útiles como inhibidores de proteína quinasas.
|
CA2679701A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines useful as inhibitors of protein kinases
|
WO2008128009A2
(en)
|
2007-04-13 |
2008-10-23 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
EP2152696B1
(en)
|
2007-05-02 |
2014-09-24 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
WO2008137622A2
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
JP5389785B2
(ja)
*
|
2007-05-02 |
2014-01-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤として有用なチアゾールおよびピラゾール
|
CA2687966A1
(en)
*
|
2007-05-24 |
2008-12-04 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
WO2009018415A1
(en)
|
2007-07-31 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
RU2011112802A
(ru)
*
|
2008-09-03 |
2012-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Сокристаллы и содержащие их фармацевтические композиции
|
DE102009004245A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
|
WO2014017936A2
(en)
|
2012-07-24 |
2014-01-30 |
Bial- Portela & Ca, S.A. |
Urea compounds and their use as enzyme inhibitors
|
US20150197503A1
(en)
*
|
2012-07-27 |
2015-07-16 |
Bial-Portela & Cª, S.A. |
Process for the synthesis of substituted urea compounds
|
JP6449277B2
(ja)
|
2013-07-24 |
2019-01-09 |
ビアル−ポルテラ エ コンパニア,ソシエダッド アノニマ |
イミダゾールカルボキサミドおよびfaah阻害剤としてのそれらの使用
|